Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1990 Jun;40(6):700-4.

[Comparative Bioavailability of Eicosapentaenoic Acid and Docasahexaenoic Acid From Triglycerides, Free Fatty Acids and Ethyl Esters in Volunteers]

[Article in German]
Affiliations
  • PMID: 2144420
Clinical Trial

[Comparative Bioavailability of Eicosapentaenoic Acid and Docasahexaenoic Acid From Triglycerides, Free Fatty Acids and Ethyl Esters in Volunteers]

[Article in German]
B Beckermann et al. Arzneimittelforschung. .

Abstract

Comparative Bioavailability of Eicosapentaenoic Acid and Docosahexaenoic Acid from Triglycerides, Free Fatty Acids and Ethyl Esters in Volunteers. The bioavailability of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) from triglycerides, free fatty acids and ethyl esters was investigated in 8 female volunteers in a randomized triple cross-over trial with baseline control. EPA/DHA was administered in capsules in form of triglycerides (1.68/0.72 g), free fatty acids (1.35/1.065 g) and ethyl esters (1.86/1.27 g). The resulting EPA/DHA plasma levels were determined and evaluated. The mean relative bioavailability of EPA/DHA compared to triglycerides was 186/136% from free fatty acids and 40/48% from ethyl esters. Maximal plasma levels were about 50% higher with free fatty acids and about 50% lower with ethyl esters as compared to triglycerides. The tolerability of the free fatty acids was much worse than that of triglycerides and ethyl esters. The main side effect was eructation.

Similar articles

See all similar articles

Cited by 15 articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback